Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Minh V. Huynh"'
Autor:
Norman E. Sharpless, Sharon L. Campbell, Bruce C. Baguley, Michael J. Miley, Daniel C. Zedek, David B. Darr, George P. Souroullas, William R. Jeck, Brit L. Martin, Kailing Fu, Kelly S. Clark, James E. Gillahan, Meriam A. Waqas, Minh V. Huynh, Wenjin Liu, Christin E. Burd
Figure S1. Generation of the LSL-N-RasQ61R allele. Figure S2. Conditional expression of N-Ras mutants does not alter melanocyte morphology. Figure S3. In both the heterozygous and homozygous state, NRasG12D fails to induce melanoma formation. Figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a5c3e3adfbf56270fa607f7d8df27f8
https://doi.org/10.1158/2159-8290.22530242.v1
https://doi.org/10.1158/2159-8290.22530242.v1
Autor:
Norman E. Sharpless, Sharon L. Campbell, Bruce C. Baguley, Michael J. Miley, Daniel C. Zedek, David B. Darr, George P. Souroullas, William R. Jeck, Brit L. Martin, Kailing Fu, Kelly S. Clark, James E. Gillahan, Meriam A. Waqas, Minh V. Huynh, Wenjin Liu, Christin E. Burd
NRAS mutation at codons 12, 13, or 61 is associated with transformation; yet, in melanoma, such alterations are nearly exclusive to codon 61. Here, we compared the melanoma susceptibility of an NrasQ61R knock-in allele to similarly designed KrasG12D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b07545ea77a4bfaa05fa90bb50b2e69
https://doi.org/10.1158/2159-8290.c.6546137.v1
https://doi.org/10.1158/2159-8290.c.6546137.v1
Autor:
Minh V, Huynh, G Aaron, Hobbs, Antje, Schaefer, Mariaelena, Pierobon, Leiah M, Carey, J Nathaniel, Diehl, Jonathan M, DeLiberty, Ryan D, Thurman, Adelaide R, Cooke, Craig M, Goodwin, Joshua H, Cook, Lin, Lin, Andrew M, Waters, Naim U, Rashid, Emanuel F, Petricoin, Sharon L, Campbell, Kevin M, Haigis, Diane M, Simeone, Costas A, Lyssiotis, Adrienne D, Cox, Channing J, Der
Publikováno v:
Sci Signal
Although oncogenic driver mutations in RAS occur in 20% of cancers, heterogeneity in the biologic outputs of different RAS mutants has hampered efforts to develop effective treatments for RAS-mutated cancers. In this issue of Science Signaling, Huynh
Autor:
Minh V. Huynh, G. Aaron Hobbs, Antje Schaefer, Mariaelena Pierobon, Leiah M. Carey, J. Nathaniel Diehl, Jonathan M. DeLiberty, Ryan D. Thurman, Adelaide R. Cooke, Craig M. Goodwin, Joshua H. Cook, Lin Lin, Andrew M. Waters, Naim U. Rashid, Emanuel F. Petricoin, Sharon L. Campbell, Kevin M. Haigis, Diane M. Simeone, Costas A. Lyssiotis, Adrienne D. Cox, Channing J. Der
Publikováno v:
Science Signaling. 15
Missense mutations at the three hotspots in the guanosine triphosphatase (GTPase) RAS—Gly 12 , Gly 13 , and Gln 61 (commonly known as G12, G13, and Q61, respectively)—occur differentially among the three RAS isoforms. Q61 mutations in KRAS are in
Autor:
Minh V. Huynh, Derek Parsonage, Tom E. Forshaw, Venkata R. Chirasani, G. Aaron Hobbs, Hanzhi Wu, Jingyun Lee, Cristina M. Furdui, Leslie B. Poole, Sharon L. Campbell
The development of mutant-selective inhibitors for the KRASG12C allele has generated considerable excitement. These KRASG12C inhibitors covalently engage the mutant C12 thiol located within the phosphoryl binding loop of RAS, locking the KRASG12C pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d179fea6ae88ced5795a169e74ee2824
https://doi.org/10.1101/2022.04.03.486828
https://doi.org/10.1101/2022.04.03.486828
Autor:
Minh V. Huynh, Derek Parsonage, Tom E. Forshaw, Venkat R. Chirasani, G. Aaron Hobbs, Hanzhi Wu, Jingyun Lee, Cristina M. Furdui, Leslie B. Poole, Sharon L. Campbell
Publikováno v:
Journal of Biological Chemistry. 298:102186
The recent development of mutant-selective inhibitors for the oncogenic KRAS
Autor:
Guowei Yin, Nora Kuhlmann, Channing J. Der, Rachel Bagni, Samantha K. Kistler, Sharon L. Campbell, Leslie Garvey, Minh V. Huynh, Samuel D. George, Michael Lammers
Publikováno v:
Journal of Biological Chemistry. 292:4446-4456
The KRAS GTPase plays a critical role in the control of cellular growth. The activity of KRAS is regulated by guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and also post-translational modification. Lysine 104 in KRAS
Autor:
Christin E. Burd, Michael J. Miley, Wenjin Liu, Bruce C. Baguley, David B. Darr, Norman E. Sharpless, Meriam A. Waqas, Brit L. Martin, Kailing Fu, William R. Jeck, Kelly S. Clark, George P. Souroullas, Daniel C. Zedek, Minh V. Huynh, Sharon L. Campbell, James E. Gillahan
Publikováno v:
Cancer Discovery. 4:1418-1429
NRAS mutation at codons 12, 13, or 61 is associated with transformation; yet, in melanoma, such alterations are nearly exclusive to codon 61. Here, we compared the melanoma susceptibility of an NrasQ61R knock-in allele to similarly designed KrasG12D
Autor:
Atsuo T. Sasaki, Aaron Hobbs, Sharon L. Campbell, Rachael Baker, Henrik G. Dohlman, Minh V. Huynh
Publikováno v:
Molecular Cancer Research. 12:IA18-IA18
Ras proteins are critical regulators of multiple pathways involved in cellular growth control. Activating mutations in Ras genes are found in 33% of human cancers, with Ras well recognized as the most commonly mutated oncogene in human cancer. Mutati